We are live on ! Find out more
EUDAW icon

EUDA Health Holdings Warrant

12 hedge funds and large institutions have $568K invested in EUDA Health Holdings Warrant in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% less capital invested

Capital invested by funds: $573K → $568K (-$4.65K)

8% less funds holding

Funds holding: 1312 (-1)

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
12
Holders Change
-1
Holders Change %
-7.69%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
2
Reduced
4
Closed
1
Calls
Puts
Net Calls
Net Calls Change

EUDAW Hedge Fund Activity: Q1 2023 in Review

12 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in EUDA Health Holdings Warrant (EUDAW) for Q1 2023, worth a combined $568K — down 0.81% from $573K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of EUDAW and 0 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 2 added.

The largest buyer was Walleye Capital, adding an estimated $6.61K. The largest seller was AQR Arbitrage, cutting an estimated $7.94K.

  • 12 institutional investors held EUDA Health Holdings Warrant (EUDAW) as of Q1 2023, down from 13 in Q4 2022.
  • Funds reported $568K of EUDA Health Holdings Warrant stock for Q1 2023, down 0.81% quarter-over-quarter.
  • 0 funds opened new EUDA Health Holdings Warrant positions in Q1 2023 and 1 closed out, a net change of -1 holder.
  • The largest EUDA Health Holdings Warrant buyer in Q1 2023 was Walleye Capital, an estimated $6.61K added.
  • The largest EUDA Health Holdings Warrant seller in Q1 2023 was AQR Arbitrage, an estimated $7.94K sold.

Based on aggregated 13F filings for Q1 2023.